CEO & CSO of OncoBone Ventures interviewed on Proactive Investors

“Dr Jussi Halleen, CEO and Dr Tiina Kähkönen, CSO of OncoBone Ventures joined Katie Pilbeam at Proactive Investors to talk about their work to develop novel therapies for cancer patients with currently incurable bone metastases”

OncoBone Ventures (www.oncoboneventures.com), a UK start-up biotech company seeking to develop novel therapies for cancer patients with currently incurable bone metastases, is pleased to announce that Dr Jussi Halleen, Chief Executive Officer and Dr Tiina Kähkönen, Chief Scientific Officer of OncoBone Ventures have been interviewed by Proactive Investors on their recent visit to London. During the interview they both provided an update on the Company’s ambition to address cancer bone metastases, representing a significant unmet medical need.

A link to the interview is detailed below:
https://www.proactiveinvestors.co.uk/companies/news/983362/oncobone-ventures-ltd-on-treating-bonemetastasis-983362.html

The Proactive Investors interview is also available on Linkedin, as below:
https://www.linkedin.com/feed/update/urn:li:activity:6940544033341534208/